ALISSA WHITTAKER: Open Payments
NPI 1033540638 · PLYMOUTH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 10 payments from 9 companies in 2025. Trend: 2023 $724 · 2024 $391 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 2 | $51 |
| Alkermes, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
| Braeburn Inc. | 1 | $15 |
Products named: REXULTI, ARISTADA, INGREZZA, Dexcom G6 Transmitter, Qelbree, VRAYLAR, BRIXADI.
Industry payments across IN — which companies pay providers there.
